We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

68 hedge funds and large institutions have $61.6M invested in BioDelivery Sciences International, Inc. in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $187K | Put options by funds: $65K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 7068 (-2)

22% less capital invested

Capital invested by funds: $79.3M → $61.6M (-$17.8M)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

Holders
68
Holders Change
-2
Holders Change %
-2.86%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
16
Reduced
22
Closed
8
Calls
$187K
Puts
$65K
Net Calls
+$122K
Net Calls Change
+$22K
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
$257K +$21.7K +9,274 +9%
SKK
27
Shepherd Kaplan Krochuk
Massachusetts
$189K
State Street
28
State Street
Massachusetts
$159K +$12.7K +5,436 +8%
Wells Fargo
29
Wells Fargo
California
$151K +$777 +332 +0.5%
ARTA
30
A.R.T. Advisors
New York
$140K -$172K -73,627 -54%
Goldman Sachs
31
Goldman Sachs
New York
$134K -$37.8K -16,159 -21%
NFG
32
Next Financial Group
Texas
$132K
Renaissance Technologies
33
Renaissance Technologies
New York
$119K -$948K -404,900 -88%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$119K +$18.5K +7,891 +18%
Barclays
35
Barclays
United Kingdom
$118K -$46.9K -20,017 -28%
ACS
36
Archford Capital Strategies
Illinois
$118K
VF
37
Virtu Financial
New York
$106K +$2.93K +1,251 +3%
Simplex Trading
38
Simplex Trading
Illinois
$103K -$89.4K -38,179 -45%
WAM
39
Weiss Asset Management
Massachusetts
$101K +$53K +22,664 +103%
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$93K -$16.6K -7,082 -15%
CCB
41
Cutter & Co Brokerage
Missouri
$88K -$7.02K -3,000 -7%
VNA
42
Valley National Advisers
Pennsylvania
$85K
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$78K +$80.7K +34,460 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$77K -$199K -85,206 -71%
UBS Group
45
UBS Group
Switzerland
$44K +$4.37K +1,867 +11%
SIC
46
Salem Investment Counselors
North Carolina
$39K
CAM
47
Close Asset Management
United Kingdom
$37K
Citadel Advisors
48
Citadel Advisors
Florida
$35K -$166K -70,808 -82%
SPC
49
Sigma Planning Corp
Michigan
$33K
Balyasny Asset Management
50
Balyasny Asset Management
Illinois
$26K -$7.77K -3,319 -23%

BDSI Hedge Fund Activity: Q1 2018 in Review

68 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2018, worth a combined $61.6M — down 22% from $79.3M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BDSI and 6 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was Avoro Capital Advisors, adding an estimated $6.95M. The largest seller was Bank of Montreal, exiting entirely with an estimated $2.9M sold.

  • 68 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2018, down from 70 in Q4 2017.
  • Funds reported $61.6M of BioDelivery Sciences International, Inc. stock for Q1 2018, down 22% quarter-over-quarter.
  • 6 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2018 and 8 closed out, a net change of -2 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q1 2018 was Avoro Capital Advisors, an estimated $6.95M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q1 2018 was Bank of Montreal, an estimated $2.9M sold.

Based on aggregated 13F filings for Q1 2018.